Literature DB >> 8302770

Scaleup of oral extended-release dosage forms.

J P Skelly, G A Van Buskirk, H M Arbit, G L Amidon, L Augsburger, W H Barr, S Berge, J Clevenger, S Dighe, M Fawzi.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8302770     DOI： 10.1023/a:1018946819849

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  3 in total

1.  A history of biopharmaceutics in the Food and Drug Administration 1968-1993.

Authors:  Jerome Philip Skelly
Journal:  AAPS J       Date:  2009-11-20       Impact factor: 4.009

2.  Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation.

Authors:  N D Eddington; P Marroum; R Uppoor; A Hussain; L Augsburger
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

Review 3.  Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.

Authors:  Glenn A Van Buskirk; Satish Asotra; Christopher Balducci; Prabir Basu; Gerald DiDonato; Angelica Dorantes; W Mark Eickhoff; Tapash Ghosh; Mario A González; Theresa Henry; Matthew Howard; Jason Kamm; Steven Laurenz; Ryan MacKenzie; Richard Mannion; Patrick K Noonan; Terrance Ocheltree; Umesh Pai; Richard P Poska; Michael L Putnam; Ramani R Raghavan; Colleen Ruegger; Eric Sánchez; Vinod P Shah; Zezhi Jesse Shao; Russell Somma; Vijay Tammara; Avinash G Thombre; Bruce Thompson; Robert J Timko; Satyam Upadrashta; Sivakumar Vaithiyalingam
Journal:  AAPS PharmSciTech       Date:  2014-03-01       Impact factor: 3.246
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.